Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study

BACKGROUND: Vedolizumab has become a standard treatment for the inflammatory bowel diseases ulcerative colitis (UC) and Crohn’s disease (CD). However, there is an ongoing debate on the ideal individual treatment algorithms and means to predict treatment response are not routinely established. AIMS:...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Gastroenterol
Autori principali: Mühl, Laura, Becker, Emily, Müller, Tanja M., Atreya, Raja, Atreya, Imke, Neurath, Markus F., Zundler, Sebastian
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7821503/
https://ncbi.nlm.nih.gov/pubmed/33482730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-021-01604-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi